Smith+Nephew Announces 510(K) Clearance Of Its AETOS Shoulder System For Anatomic And Reverse Shoulder Replacement
Portfolio Pulse from Benzinga Newsdesk
Smith+Nephew has received FDA 510(k) clearance for its AETOS Shoulder System, designed for anatomic and reverse shoulder replacement. The system aims to restore patients' range-of-motion and minimize arthritic shoulder pain. Total shoulder arthroplasty is expected to reach 250,000 procedures in the US by 2025.
June 12, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Smith+Nephew receives FDA clearance for its AETOS Shoulder System, potentially boosting its position in the growing total shoulder arthroplasty market.
The FDA clearance of Smith+Nephew's AETOS Shoulder System allows the company to enter the growing total shoulder arthroplasty market, which is expected to reach 250,000 procedures in the US by 2025. This clearance could lead to increased sales and market share for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100